Tatar G, Alcin G, Sengul Samanci N, Erol Fenercioglu O, et al. Role of 18F-FDG PET/CT in the assessment of therapy response and clinical outcome in metastatic renal cell carcinoma treated with tyrosine kinase inhibitors or immunotherapy. Nucl Med Commun 2022 Apr 1. pii: 00006231-990000000-00004.
PMID: 35362692